| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.zenotechlab.com | |
| Market Cap | 313.15 Cr. | |
| Enterprise Value(EV) | 313.15 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.90 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 27.03 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 31.87 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 13.48 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 3.81 | Calculated using Price: 51.31 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 6.10 Cr. | 61,030,568 Shares |
| FaceValue | 10 | |
| About Zenotech Laboratories Ltd. | ||
| Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world. | ||
| 1 Day |
|
-0.60% |
| 1 Week |
|
-1.92% |
| 1 Month |
|
-7.79% |
| 3 Month |
|
+1.69% |
| 6 Month |
|
-20.93% |
| 1 Year |
|
-10.37% |
| 2 Year |
|
+22.89% |
| 5 Year |
|
+31.61% |
| 10 Year |
|
+87.57% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -155.73 | -7.73 | 24.35 | -2.48 | 37.26 | |||||
| Return on Capital Employed (%) | -39.28 | -61.52 | -65.68 | -61.88 | -5.95 | 18.32 | 0.48 | 15.26 | ||
| Return on Assets (%) | -33.32 | -45.43 | -32.82 | -38.33 | -17.89 | -3.76 | 12.67 | -1.42 | 26.45 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | 3 | -27 | -46 | -66 | 42 | 39 | 50 | 48 | 71 | 82 | |
| Non Curr. Liab. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | -4 | -7 | |
| Curr. Liab. | 66 | 91 | 99 | 116 | 39 | 45 | 35 | 15 | 16 | 17 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 70 | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | 92 | |
| Non Curr. Assets | 59 | 55 | 50 | 49 | 50 | 65 | 80 | 79 | 74 | 75 | |
| Curr. Assets | 11 | 8 | 3 | 2 | 31 | 19 | 6 | 7 | 7 | 16 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 70 | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | 92 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
| Net Sales | 3 | 4 | 2 | 2 | 11 | 13 | 26 | 22 | 37 | 42 | |
| Other Income | 3 | 0 | 0 | 0 | 2 | 5 | 1 | 0 | 1 | 1 | |
| Total Income | 5 | 4 | 2 | 2 | 14 | 18 | 27 | 23 | 37 | 44 | |
| Total Expenditure | -20 | -24 | -10 | -13 | -19 | -17 | -17 | -16 | -19 | -22 | |
| PBIDT | -15 | -20 | -8 | -10 | -6 | 1 | 10 | 7 | 18 | 22 | |
| Interest | -5 | -7 | -8 | -8 | -2 | 0 | -1 | -2 | -1 | 0 | |
| Depreciation | -4 | -4 | -4 | -4 | -4 | -4 | -5 | -6 | -7 | -7 | |
| Taxation | 12 | -3 | |||||||||
| Exceptional Items | 2 | 6 | |||||||||
| PAT | -23 | -30 | -19 | -20 | -12 | -3 | 11 | -1 | 22 | 12 | |
| Adjusted EPS | -6 | -8 | -5 | -5 | -2 | -1 | 2 | 0 | 4 | 2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -10 | -24 | -8 | -5 | 2 | -16 | -14 | 11 | 6 | 18 | |
| Cash Fr. Inv. | 0 | -1 | 0 | 6 | -1 | -3 | -16 | -21 | -5 | -2 | |
| Cash Fr. Finan. | 10 | 30 | 7 | -1 | -1 | 47 | 15 | -3 | 0 | -16 | |
| Net Change | 0 | 5 | -1 | 0 | 0 | 28 | -15 | -12 | 1 | 0 | |
| Cash & Cash Eqvt | 2 | 6 | 6 | 0 | 0 | 28 | 13 | 1 | 2 | 2 |
|
Mon, 22 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Regulation 24A of the Listing Regulations we enclose herewith the Annual Secretarial Compliance Report for the Financial Year ended March 31 2023 issued by Mr. Mahadev Tirunagari Practicing Company Secretary Hyderabad. |
|||||||||||||||||||||
|
Wed, 03 May 2023
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Abdul Gafoor Mohammad Designation: Company Secretary and Compliance Officer EmailId: abdul.gafoor@zenotech.co.in Name of the Chief Financial Officer: Poly K V Designation: Chief Financial Officer EmailId: polykv@zenotec.co.in Date: 03/05/2023 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
|
Fri, 28 Apr 2023
Submission Of Audited Standalone Financial Results Of Zenotech Laboratories Limited ('The Company') For The Quarter And Financial Year Ended March 31 2023 Pursuant to the Regulation 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the Board of Directors of the Company at its meeting held today i.e. April 28 2023 have considered and approved the Audited Standalone Financial Results of the Company for the quarter and financial year ended on March 31 2023 along with the Report of Auditors thereon andA Declaration (Unmodified opinion) under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is also enclosed. The meeting of the Board of Directors commenced at 5:30 PM and concluded at 7:50 PM.The aforesaid information is also being uploaded on the Companys website at www.zenotechlab.com. |
| Fri, 26 May 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Closing Below Previous Low
|
Close Within 52 Week Low Zone
|
Equities
M.F.
Sectors
StockEdge Social